Quality Bio-Specimens for Novel Biomarker Discovery
نویسندگان
چکیده
منابع مشابه
Novel automated biomarker discovery work flow for urinary peptidomics.
BACKGROUND Urine is potentially a rich source of peptide biomarkers, but reproducible, high-throughput peptidomic analysis is often hampered by the inherent variability in factors such as pH and salt concentration. Our goal was to develop a generally applicable, rapid, and robust method for screening large numbers of urine samples, resulting in a broad spectrum of native peptides, as a tool to ...
متن کاملMetabolomics for Biomarker Discovery
Metabolomics is the study of the small molecule biochemistry of an organism. The goal is to understand the metabolic state of a subject by extracting, identifying and quantifying all of the small molecule compounds (for example, metabolites) in a biological sample. Since it is based upon biochemistry and provides a measurement of the biological status of an organism, metabolomics provides a pow...
متن کاملSILAC for biomarker discovery.
SILAC has been employed in MS-based proteomics for nearly a decade. This method is based on cells in culture metabolically incorporating isotope-coded essential amino acids and allows the quantification of global protein populations to identify characteristic changes. Variations of this technique developed over the years allow the application of SILAC not only to cell culture derived samples bu...
متن کاملProteomics for Cancer Biomarker Discovery
Background: If we are to successfully treat cancer, we must understand the biologic underpinnings in conjunction with early diagnosis. Genome-wide expression studies have advanced the research of many cancers. Nevertheless, understanding which genes are expressed in a tumor is not equivalent to knowing which proteins are being produced. Proteomics hold great promise for careful examination of t...
متن کاملBiomarker discovery for heterogeneous diseases.
BACKGROUND Modern genomic and proteomic studies reveal that many diseases are heterogeneous, comprising multiple different subtypes. The common notion that one biomarker can be predictive for all patients may need to be replaced by an understanding that each subtype has its own set of unique biomarkers, affecting how discovery studies are designed and analyzed. METHODS We used Monte Carlo sim...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Translational Medicine
سال: 2012
ISSN: 2161-1025
DOI: 10.4172/2161-1025.s1-007